This indicates that GLP-1 is involved in the formation of constipation, but the underlying mechanism remains unclear
And I think we're entering a chapter that will fundamentally change how we treat obesity and its metabolic complications
Research Overview As a research-use-only compound, BPC-157 is commonly investigated in studies focused on peptide biology, cellular repair mechanisms, gastrointestinal research models, vascular response pathways, and molecular signaling activity
That's the clinical baseline
First thing that comes to my mind is that compounded is cheaper so cost and access and continuity are not as much of an issue
Moreover, GLP-1 receptor agonist use was also associated with significantly lower cartilage-loss velocity in the medial femorotibial joint (adjusted mean difference, 0.02 mm